» Articles » PMID: 39434880

Effects and Mechanisms of on Cancers Development and Immunotherapy

Overview
Journal Front Immunol
Date 2024 Oct 22
PMID 39434880
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor immunotherapy has been widely used in clinical treatment of various cancers. However, some patients of these cancers do not respond to immunotherapy effectively. And infection has been considered to be related to the efficacy of immunotherapy. This review aims to summarize the different effects and mechanisms of infection on immunotherapy in different kinds of cancers. We searched the relevant literature on and tumor immunotherapy, and summarized to form a review. Generally, infection plays a role in affecting kinds of cancers' development, besides gastric cancer. Current evidence suggests that infection may reduce the efficacy of immunotherapy for colorectal cancer, non-small cell lung cancer and melanoma, but due to the lack of sufficient evidence, more data is needed to prove that. While for gastric cancer, the effects remain controversial. The regulation effects and metabolisms involved in systematic related cancers should be paid attention to. Whether should be eradicated when immunotherapy performed may be a critical consideration for some kinds of tumors.

Citing Articles

Negative response to immunotherapy in dMMR or MSI-H gastric cancer with APC and PTEN mutations: a case report.

Liu J, Zhang X, Ren Q, Song C, Yu J, Cai Y Front Oncol. 2024; 14:1484802.

PMID: 39669365 PMC: 11634749. DOI: 10.3389/fonc.2024.1484802.

References
1.
Zhang Y, Zhang Z . The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020; 17(8):807-821. PMC: 7395159. DOI: 10.1038/s41423-020-0488-6. View

2.
Mentis A, Lehours P, Megraud F . Epidemiology and Diagnosis of Helicobacter pylori infection. Helicobacter. 2015; 20 Suppl 1:1-7. DOI: 10.1111/hel.12250. View

3.
Wang T, Du M, Ji Z, Ding C, Wang C, Men Y . Recombinant protein rMBP-NAP restricts tumor progression by triggering antitumor immunity in mouse metastatic lung cancer. Can J Physiol Pharmacol. 2017; 96(2):113-119. DOI: 10.1139/cjpp-2017-0186. View

4.
Fujimori S . Progress in elucidating the relationship between infection and intestinal diseases. World J Gastroenterol. 2022; 27(47):8040-8046. PMC: 8704277. DOI: 10.3748/wjg.v27.i47.8040. View

5.
Xue L, Mao X, Liu X, Gao H, Chen Y, Dai T . Activation of CD3 T cells by Helicobacter pylori DNA vaccines in potential immunotherapy of gastric carcinoma. Cancer Biol Ther. 2019; 20(6):866-876. PMC: 6605983. DOI: 10.1080/15384047.2019.1579957. View